about
Cancer as a metabolic diseaseTargeting energy metabolism in brain cancer: review and hypothesisCardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancerAbsence of pathogenic mitochondrial DNA mutations in mouse brain tumorsOn the origin of cancer metastasisGanglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouseGanglioside GM3 Is Antiangiogenic in Malignant Brain CancerInfluence of caloric restriction on constitutive expression of NF-κB in an experimental mouse astrocytomaDynamic simulation of cardiolipin remodeling: greasing the wheels for an interpretative approach to lipidomics.Genetic linkage between the AH locus and a major gene that inhibits susceptibility to audiogenic seizures in mice.Genetic analysis of audiogenic seizure susceptibility in C57BL/6J X DBA/2J recombinant inbred strains of mice.Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy.A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice.Behavioral seizure correlates in animal models of epilepsy: a road map for assay selection, data interpretation, and the search for causal mechanisms.Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report.Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice.AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survivalExperimental models of multifactorial epilepsies: the EL mouse and mice susceptible to audiogenic seizures.A mathematical model for the determination of steady-state cardiolipin remodeling mechanisms using lipidomic data.Genetic analysis of nucleotide triphosphatase activity in the mouse brain.Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse.Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.Perspectives on the mesenchymal origin of metastatic cancerRole of glucose and ketone bodies in the metabolic control of experimental brain cancer.The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.Meal frequency and timing in health and disease.The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer.Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans.Brain lipid analysis in mice with Rett syndromeLipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria.Filipin recognizes both GM1 and cholesterol in GM1 gangliosidosis mouse brain.Myelin abnormalities in the optic and sciatic nerves in mice with GM1-gangliosidosisPerspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies.The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer.Hypothesis: are neoplastic macrophages/microglia present in glioblastoma multiforme?The role of metabolic therapy in treating glioblastoma multiforme.Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses.Molecular basis for heterosis for myelin basic protein content in miceNon-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy.Dietary restriction promotes vessel maturation in a mouse astrocytoma.
P50
Q21245061-974E8852-01B2-4A1B-B5A3-2F53052D66CDQ24537119-806AD701-28D0-450E-B13C-5974FB03E58BQ24658168-E6927466-A352-4B9E-BF13-8BF44CA15416Q24811339-8D05927F-AF87-4624-B862-BFE565C86E33Q26865675-DC58B4F9-1333-4F1D-96B7-8B9F7E7470D1Q28344350-0DEDF6BD-640F-476E-85C2-252D93B7A21CQ28397085-D73D0776-5241-48BA-B7FA-6844F7B94980Q28477560-D2BC1BDC-14C9-4893-A9C6-DC1018FF11C1Q30495485-42F05946-66CF-47D7-A8EF-706F4EF4036DQ30498707-903EF309-15A1-415B-86AD-176AB520BFFFQ30498712-D288434D-8C47-4F6B-9588-77267E909267Q30541192-F3108A43-CA4F-4221-BED0-2EC6ADACFE8AQ30559496-6B113BC4-1096-4EF8-B21B-9E53CD8B0B10Q31029483-A14EFB80-F187-4383-82CB-36A80C41CC8CQ33562229-CAA2A493-BA10-4D2F-B946-CF07FDC21E58Q33718016-D6ED08C6-D211-44EF-9E03-FEFD051FE5CDQ33728295-18150EA8-F0F2-42FB-9B60-DF261EF9606EQ33748325-953847F2-8EC7-4BCD-99E7-3C2A3F4D3169Q33939499-BE857E04-6C6E-44FB-B211-9D42F5437ACDQ33962899-2CDF18F6-0B6E-4DAF-B090-F1B3286CB0D7Q34014571-EFF5DFA4-688E-42E0-A555-C52CCBA53050Q34158731-B668BA3F-E010-4793-BF5A-E1BA6376CCB0Q34233764-85EEB57C-8C46-4F78-8E38-6392A9523342Q34542313-F1DA320D-BF7B-49AF-951D-0618BA1BFDC1Q34576016-3A02C900-58D9-4F48-813A-C9CCFD40AEAEQ34601517-B01F4E02-AC52-4E09-96AF-03623C6F1382Q34766593-25355958-4137-4327-959D-F39320A981B4Q34804059-B6BF0305-1211-4541-B4C2-AA5F38F5A0B5Q34855127-FCC2AAAE-B0F8-4F20-AA18-BEAB949A21B1Q35013455-7771EF5E-0897-4EDB-9C91-7BC95D921599Q35067305-C77436D4-3A40-426A-BA34-A42E0EE0A174Q35126311-3935C19D-B3BD-4347-8443-E40249E33354Q35177463-4BB3CA43-3702-4D8E-8506-196456344E7EQ35200938-F8D2249F-A591-4D22-A038-BE3C137DD973Q35227405-C4B7E351-DF3B-42DB-A5FE-D768BFA15A95Q35519662-CE13F293-BD52-4399-BB3E-302B1441466AQ35536363-71603D8C-24CF-4ECD-A6C1-F7644BEC999FQ35593828-78EE1E1F-13E3-4346-9863-DA7CDE041FE8Q35660112-EB6AFA6C-165A-4D87-9573-BC12D032180FQ35664431-FF84171F-F2AA-41FE-9DFE-0F6EF45747CF
P50
description
onderzoeker, neurogeneticus en biochemicus
@nl
researcher, neurogenetic and biochemist
@en
հետազոտող
@hy
name
Thomas N Seyfried
@en
Thomas N Seyfried
@es
Thomas N Seyfried
@nl
Thomas N Seyfried
@sl
Thomas Seyfried
@fr
type
label
Thomas N Seyfried
@en
Thomas N Seyfried
@es
Thomas N Seyfried
@nl
Thomas N Seyfried
@sl
Thomas Seyfried
@fr
prefLabel
Thomas N Seyfried
@en
Thomas N Seyfried
@es
Thomas N Seyfried
@nl
Thomas N Seyfried
@sl
Thomas Seyfried
@fr
P1015
P214
P227
P244
P269
P5034
P5361
P1015
P106
P108
P1207
n2013190320
P1280
P21
P213
0000 0003 7137 8775
P214
P227
1027814298
P244
n2012185619
P269
P31
P496
0000-0003-1491-3989
P5034
KAC201515448
P5361
SeyfriedThomasN1946-
P569
1946-07-25T00:00:00Z
P691
mub2014831607